TABLE 5.
Ranking of the top 10 co-cited references for gut microbiota research in the heart failure field.
| Ranking | Cited by | References | Title | Source title | Year of publication | Type of document |
| 1 | 64 | Tang et al. (15) | Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis | Journal of the American College of Cardiology | 2014 | Article |
| 2 | 63 | Koeth et al. (16) | Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis | Nature Medicine | 2013 | Article |
| 3 | 58 | Tang et al. (17) | Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk | The New England Journal of Medicine | 2013 | Article |
| 4 | 49 | Marques et al. (26) | High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice | Circulation | 2017 | Article |
| 5 | 48 | Wang et al. (27) | Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease | Nature | 2011 | Article |
| 6 | 47 | Yang et al. (28) | Gut dysbiosis is linked to hypertension | Hypertension | 2015 | Article |
| 7 | 46 | Wang et al. (29) | Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis | Cell | 2015 | Article |
| 8 | 45 | Pasini et al. (30) | Pathogenic gut flora in patients with chronic heart failure | JACC Heart Failure | 2016 | Article |
| 9 | 41 | Luedde et al. (31) | Heart failure is associated with depletion of core intestinal microbiota | ESC Heart Failure | 2017 | Article |
| 10 | 41 | Zhu et al. (32) | Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk | Cell | 2016 | Article |